{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:57:09Z","timestamp":1790485029252,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58024-w","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T18:06:46Z","timestamp":1782670006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of synbiotic supplementation on cardiometabolic risk factors in overweight or obese calcium oxalate stone formers: a randomized controlled trial"],"prefix":"10.1038","volume":"16","clinical-trial-number":[{"clinical-trial-number":"irct20120913010826n35","registry":"10.18810\/irct"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-988X","authenticated-orcid":false,"given":"Niloofarsadat","family":"Maddahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-8402","authenticated-orcid":false,"given":"Azadeh","family":"Nadjarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Tabibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Kashefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayyed Abbas","family":"Tabatabai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"58024_CR1","doi-asserted-by":"publisher","first-page":"3068365","DOI":"10.1155\/2018\/3068365","volume":"2018","author":"T Alelign","year":"2018","unstructured":"Alelign, T. & Petros, B. Kidney stone disease: an update on current concepts. Adv. Urol. 2018, 3068365 (2018).","journal-title":"Adv. Urol."},{"key":"58024_CR2","doi-asserted-by":"publisher","first-page":"127663","DOI":"10.1016\/j.micres.2024.127663","volume":"282","author":"C Noonin","year":"2024","unstructured":"Noonin, C. & Thongboonkerd, V. Beneficial roles of gastrointestinal and urinary microbiomes in kidney stone prevention via their oxalate-degrading ability and beyond. Microbiol. Res. 282, 127663 (2024).","journal-title":"Microbiol. Res."},{"key":"58024_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/mmr.2020.11819","volume":"23","author":"E Zhao","year":"2021","unstructured":"Zhao, E. et al. Intestinal dysbacteriosis leads to kidney stone disease. Mol. Med. Rep. 23, 180 (2021).","journal-title":"Mol. Med. Rep."},{"key":"58024_CR4","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1136\/gutjnl-2017-315734","volume":"67","author":"A Ticinesi","year":"2018","unstructured":"Ticinesi, A. et al. Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67, 2097\u20132106 (2018).","journal-title":"Gut"},{"key":"58024_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/nu12020548","volume":"12","author":"A Ticinesi","year":"2020","unstructured":"Ticinesi, A. et al. Calcium oxalate nephrolithiasis and gut microbiota: not just a gut-kidney axis. a nutritional perspective. Nutrients 12, 548 (2020).","journal-title":"Nutrients"},{"issue":"5","key":"58024_CR6","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/mco2.70168","volume":"6","author":"Y Shen","year":"2020","unstructured":"Shen, Y. et al. Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm 6 (5), e70168 (2020). (2025).","journal-title":"MedComm"},{"issue":"3","key":"58024_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.ajkd.2014.03.017","volume":"64","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Kidney stones and cardiovascular risk: a meta-analysis of cohort studies. Am. J. Kidney Dis. 64 (3), 402\u2013410 (2014).","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"58024_CR8","doi-asserted-by":"publisher","first-page":"e0330069","DOI":"10.1371\/journal.pone.0330069","volume":"20","author":"Y Chen","year":"2025","unstructured":"Chen, Y. & Liao, X. Kidney stone disease increases the risk of cardiovascular events. PLoS One. 20 (9), e0330069 (2025).","journal-title":"PLoS One"},{"key":"58024_CR9","doi-asserted-by":"publisher","first-page":"102216","DOI":"10.1016\/j.ctim.2019.102216","volume":"47","author":"A Hadi","year":"2019","unstructured":"Hadi, A., Sepandi, M., Marx, W., Moradi, S. & Parastouei, K. Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: a randomized clinical trial. Complement. Ther. Med. 47, 102216 (2019).","journal-title":"Complement. Ther. Med."},{"issue":"1","key":"58024_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.29252\/ibj.23.1.68","volume":"23","author":"L Khalili","year":"2019","unstructured":"Khalili, L. et al. The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-A levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Iran. Biomed. J. 23 (1), 68\u201377 (2019).","journal-title":"Iran. Biomed. J."},{"issue":"1","key":"58024_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12967-020-02213-2","volume":"18","author":"YW Tao","year":"2020","unstructured":"Tao, Y. W., Gu, Y. L., Mao, X. Q., Zhang, L. & Pei, Y. F. Effects of probiotics on type II diabetes mellitus: A meta-analysis. J. Transl Med. 18 (1), 30 (2020).","journal-title":"J. Transl Med."},{"issue":"1","key":"58024_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.dsx.2018.08.008","volume":"13","author":"E Razmpoosh","year":"2019","unstructured":"Razmpoosh, E. et al. The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo-controlled trial. Diabetes Metab. Syndr. 13 (1), 175\u2013182 (2019).","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"58024_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/hdi.12748","volume":"23","author":"A Kooshki","year":"2019","unstructured":"Kooshki, A., Tofighiyan, T. & Miri, M. A synbiotic supplement for inflammation and oxidative stress and lipid abnormalities in hemodialysis patients. Hemodial. Int. 23 (2), 254\u2013260 (2019).","journal-title":"Hemodial. Int."},{"issue":"1","key":"58024_CR14","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1038\/s41598-024-69560-8","volume":"14","author":"SS Matin","year":"2024","unstructured":"Matin, S. S. et al. The impact of synbiotic on serum sCD163\/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial. Sci. Rep. 14 (1), 19120 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"58024_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/fsn3.3069","volume":"11","author":"TX Zhao","year":"2022","unstructured":"Zhao, T. X. et al. Long-term use of probiotics for the management of office and ambulatory blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Food Sci. Nutr. 11 (1), 101\u2013113 (2022).","journal-title":"Food Sci. Nutr."},{"issue":"1","key":"58024_CR16","doi-asserted-by":"publisher","first-page":"e05925","DOI":"10.1016\/j.heliyon.2021.e05925","volume":"7","author":"J Bohlouli","year":"2021","unstructured":"Bohlouli, J. et al. Effect of probiotics on oxidative stress and inflammatory status in diabetic nephropathy: A systematic review and meta-analysis of clinical trials. Heliyon 7 (1), e05925 (2021).","journal-title":"Heliyon"},{"key":"58024_CR17","doi-asserted-by":"publisher","first-page":"105668","DOI":"10.1016\/j.phrs.2021.105668","volume":"169","author":"A Ghavami","year":"2021","unstructured":"Ghavami, A., Khorvash, F., Heidari, Z., Khalesi, S. & Askari, G. Effect of synbiotic supplementation on migraine characteristics and inflammatory biomarkers in women with migraine: Results of a randomized controlled trial. Pharmacol. Res. 169, 105668 (2021).","journal-title":"Pharmacol. Res."},{"key":"58024_CR18","unstructured":"Wilkens, K. G., Juneja, V. & Shanaman, E. Medical therapy for renal disorders in Krause and Mahan\u2019s food & the nutrition care process (ed. Raymond, J.L. & Morrow, K.) 727\u2013755 (Elsevier, 2021)."},{"key":"58024_CR19","unstructured":"Lysen, L. K. & Robinson, D. & Rudel. R. Nutrition in weight management in Krause and Mahan\u2019s food & the nutrition care process (ed. Raymond, J.L. & Morrow, K.) 392\u2013420 (Elsevier, 2021)."},{"key":"58024_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of Low- density lipoprotein cholesterol in plasma without use of the preparation ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"key":"58024_CR21","doi-asserted-by":"publisher","first-page":"898037","DOI":"10.3389\/fnut.2022.898037","volume":"9","author":"G Kilic Yildirim","year":"2022","unstructured":"Kilic Yildirim, G., Dinleyici, M., Vandenplas, Y. & Dinleyici, E. C. Effects of multispecies synbiotic supplementation on anthropometric measurements, glucose and lipid parameters in children with exogenous obesity: a randomized, double blind, placebo-controlled clinical trial (probesity-2 trial). Front. Nutr. 9, 898037 (2022).","journal-title":"Front. Nutr."},{"issue":"1","key":"58024_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13098-023-01094-x","volume":"15","author":"L Khalili","year":"2023","unstructured":"Khalili, L. et al. Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial. Diabetol. Metab. Syndr. 15 (1), 109 (2023).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"58024_CR23","first-page":"51","volume":"15","author":"S Darvishi","year":"2021","unstructured":"Darvishi, S., Rafraf, M., Asghari-Jafarabadi, M. & Farzadi, L. Synbiotic supplementation improves metabolic factors and obesity values in women with polycystic ovary syndrome independent of affecting apelin levels: a randomized double-blind placebo\u2014controlled clinical trial. Int. J. Fertil. Steril. 15 (1), 51\u201359 (2021).","journal-title":"Int. J. Fertil. Steril."},{"issue":"7","key":"58024_CR24","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00394-019-02135-w","volume":"59","author":"A Horvath","year":"2020","unstructured":"Horvath, A. et al. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. Eur. J. Nutr. 59 (7), 2969\u20132983 (2020).","journal-title":"Eur. J. Nutr."},{"issue":"1","key":"58024_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-020-01244-4","volume":"19","author":"E Karimi","year":"2020","unstructured":"Karimi, E. et al. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial. Lipids Health Dis. 19 (1), 60 (2020).","journal-title":"Lipids Health Dis."},{"key":"58024_CR26","doi-asserted-by":"publisher","first-page":"846873","DOI":"10.3389\/fnut.2022.846873","volume":"9","author":"G Derosa","year":"2022","unstructured":"Derosa, G. et al. Probiotic therapy with VSL#3 in patients with NAFLD: A randomized clinical trial. Front. Nutr. 9, 846873 (2022).","journal-title":"Front. Nutr."},{"issue":"1","key":"58024_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/amh70010005","volume":"70","author":"Q Oudat","year":"2025","unstructured":"Oudat, Q. & Okour, A. The role of probiotics in modulating gut microbiota and metabolic health for weight management: a mini review. Acta Microbiol. Hell. 70 (1), 5 (2025).","journal-title":"Acta Microbiol. Hell"},{"key":"58024_CR28","doi-asserted-by":"publisher","first-page":"123528","DOI":"10.1016\/j.lfs.2025.123528","volume":"369","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Advancements in the study of short-chain fatty acids and their therapeutic effects on atherosclerosis. Life Sci. 369, 123528 (2025).","journal-title":"Life Sci."},{"key":"58024_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fendo.2014.00085","volume":"5","author":"I Kimura","year":"2014","unstructured":"Kimura, I., Inoue, D., Hirano, K. & Tsujimoto, G. The SCFA receptor GPR43 and energy metabolism. Front. Endocrinol. (Lausanne). 5, 85 (2014).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"58024_CR30","doi-asserted-by":"publisher","first-page":"1237882","DOI":"10.3389\/fendo.2023.1237882","volume":"14","author":"F Fallah","year":"2023","unstructured":"Fallah, F. & Mahdavi, R. Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial. Front. Endocrinol. (Lausanne). 14, 1237882 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"58024_CR31","doi-asserted-by":"publisher","first-page":"106288","DOI":"10.1016\/j.phrs.2022.106288","volume":"182","author":"K Naseri","year":"2022","unstructured":"Naseri, K. et al. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol. Res. 182, 106288 (2022).","journal-title":"Pharmacol. Res."},{"issue":"7","key":"58024_CR32","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.3168\/jds.2010-4128","volume":"94","author":"HS Ejtahed","year":"2011","unstructured":"Ejtahed, H. S. et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy. Sci. 94 (7), 3288\u20133294 (2011).","journal-title":"J. Dairy. Sci."},{"key":"58024_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6882-11-53","volume":"11","author":"N Xie","year":"2011","unstructured":"Xie, N. et al. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement. Altern. Med. 11, 53 (2011).","journal-title":"BMC Complement. Altern. Med."},{"issue":"5","key":"58024_CR34","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1017\/S0007114508043808","volume":"101","author":"EM Hamad","year":"2009","unstructured":"Hamad, E. M. et al. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br. J. Nutr. 101 (5), 716\u2013724 (2009).","journal-title":"Br. J. Nutr."},{"issue":"4","key":"58024_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00394-016-1199-8","volume":"56","author":"S Firouzi","year":"2017","unstructured":"Firouzi, S., Majid, H. A., Ismail, A., Kamaruddin, N. A. & Barakatun-Nisak, M. Y. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. Eur. J. Nutr. 56 (4), 1535\u20131550 (2017).","journal-title":"Eur. J. Nutr."},{"issue":"5","key":"58024_CR36","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","volume":"36","author":"E Kouchaki","year":"2017","unstructured":"Kouchaki, E. et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 36 (5), 1245\u20131249 (2017).","journal-title":"Clin. Nutr."},{"issue":"2","key":"58024_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","volume":"91","author":"A Soleimani","year":"2017","unstructured":"Soleimani, A. et al. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int. 91 (2), 435\u2013442 (2017).","journal-title":"Kidney Int."},{"key":"58024_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/DMSO.S238867","volume":"13","author":"A Zare Javid","year":"2020","unstructured":"Zare Javid, A., Aminzadeh, M., Haghighi-Zadeh, M. H. & Jamalvandi, M. The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. A placebo-controlled, double-blind, randomized clinical trial. Diabetes Metab. Syndr. Obes. 13, 607\u2013617 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"11","key":"58024_CR39","first-page":"e74621","volume":"16","author":"U Pingali","year":"2024","unstructured":"Pingali, U., Kalidindi, R. K., Mekala, P. & Khan, I. A randomized double-blind placebo-controlled study on the safety and efficacy of probiotics for insulin resistance and oxidative stress markers in diabetic patients with end-stage renal disease on hemodialysis. Cureus 16 (11), e74621 (2024).","journal-title":"Cureus"},{"key":"58024_CR40","doi-asserted-by":"publisher","first-page":"846873","DOI":"10.3389\/fnut.2022.846873","volume":"9","author":"G Derosa","year":"2022","unstructured":"Derosa, G. et al. Probiotic therapy with VSL#3 in patients with NAFLD: A randomized clinical trial. Front. Nutr. 9, 846873 (2022).","journal-title":"Front. Nutr."},{"key":"58024_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.diabres.2018.02.008","volume":"138","author":"Z Nabhani","year":"2018","unstructured":"Nabhani, Z., Hezaveh, S. J. G., Razmpoosh, E., Asghari-Jafarabadi, M. & Gargari, B. P. The effects of synbiotic supplementation on insulin resistance\/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double-blind placebo controlled clinical trial. Diabetes Res. Clin. Pract. 138, 149\u2013157 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"58024_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.clnesp.2019.10.001","volume":"35","author":"E Razmpoosh","year":"2020","unstructured":"Razmpoosh, E., Zare, S., Fallahzadeh, H., Safi, S. & Nadjarzadeh, A. Effect of a low energy diet, containing a high protein, probiotic condensed yogurt, on biochemical and anthropometric measurements among women with overweight\/obesity: A randomised controlled trial. Clin. Nutr. ESPEN. 35, 194\u2013200 (2020).","journal-title":"Clin. Nutr. ESPEN"},{"key":"58024_CR43","doi-asserted-by":"publisher","first-page":"102234","DOI":"10.1016\/j.ctim.2019.102234","volume":"48","author":"S Talebi","year":"2020","unstructured":"Talebi, S., Karimifar, M., Heidari, Z., Mohammadi, H. & Askari, G. The effects of synbiotic supplementation on thyroid function and inflammation in hypothyroid patients: A randomized, double-blind, placebo-controlled trial. Complement. Ther. Med. 48, 102234 (2020).","journal-title":"Complement. Ther. Med."},{"key":"58024_CR44","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.nut.2019.110713","volume":"73","author":"S Mirzaeian","year":"2020","unstructured":"Mirzaeian, S. et al. Effects of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in patients on hemodialysis: A double-blind, placebo-controlled, randomized clinical trial. Nutrition 73, 110713 (2020).","journal-title":"Nutrition"},{"issue":"1","key":"58024_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12937-021-00703-7","volume":"20","author":"J Moludi","year":"2021","unstructured":"Moludi, J. et al. Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial. Nutr. J. 20 (1), 47 (2021).","journal-title":"Nutr. J."},{"issue":"1","key":"58024_CR46","doi-asserted-by":"publisher","first-page":"2195135","DOI":"10.1080\/10641963.2023.2195135","volume":"45","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. Gut microbiota and hypertension: association, mechanisms and treatment. Clin. Exp. Hypertens. 45 (1), 2195135 (2023).","journal-title":"Clin. Exp. Hypertens."},{"issue":"9","key":"58024_CR47","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1039\/C8FO00888D","volume":"9","author":"A Mafi","year":"2018","unstructured":"Mafi, A. et al. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double- blind, placebo-controlled trial. Food Funct. 9 (9), 4763\u20134770 (2018).","journal-title":"Food Funct."},{"key":"58024_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/DMSO.S230060","volume":"13","author":"H Bazyar","year":"2020","unstructured":"Bazyar, H. et al. The impacts of synbiotic supplementation on periodontal indices and biomarkers of oxidative stress in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial. Diabetes Metab. Syndr. Obes. 13, 19\u201329 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"58024_CR49","unstructured":"Zirker, L. Kidney-gut axis: the conection between kidney disease and the gut in Clinical guide to nutrition care in kidney disease (eds. Gonyea, J. E. & Phillips, S. C.) 3rd ed. 443\u2013453 (Academy of Nutrition and Dietetics, 2023)."},{"issue":"6","key":"58024_CR50","first-page":"17","volume":"13","author":"MJ Bull","year":"2014","unstructured":"Bull, M. J. & Plummer, N. T. Part 1: The human gut microbiome in health and disease. Integr. Med. (Encinitas). 13 (6), 17\u201322 (2014).","journal-title":"Integr. Med. (Encinitas)"},{"issue":"20","key":"58024_CR51","doi-asserted-by":"publisher","first-page":"eadl0479","DOI":"10.1126\/sciadv.adl0479","volume":"10","author":"X Li","year":"2024","unstructured":"Li, X. et al. Precise modulation and use of reactive oxygen species for immunotherapy. Sci. Adv. 10 (20), eadl0479 (2024).","journal-title":"Sci. Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58024-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58024-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58024-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:01:56Z","timestamp":1790481716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58024-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58024"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58024-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29659"}}